HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 48.050
  • +0.350+0.73%
Not Open Apr 26 16:08 CST
47.81BMarket Cap29.84P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GIANT BIOGENE Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 25, 2024

Revenue(YoY)

3.52B

+49.05%
EPS(YoY)

1.48

+53.18%
Analyst Rating

Strong Buy

Apr 28, 2024

GIANT BIOGENE Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 2.484B--
--2024/H1-- / 2.116B--
Mar 25, 20242023/H21.918B / 1.842B--
Aug 28, 20232023/H11.606B / 1.471B--
Mar 27, 20232022/H21.641B / 1.177B--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 2.484B--
--2024/H1-- / 2.116B--
Mar 25, 20242023/H21.918B / 1.842B--
Aug 28, 20232023/H11.606B / 1.471B--
Mar 27, 20232022/H21.641B / 1.177B--

GIANT BIOGENE Earnings Reports

  • GIANT BIOGENE: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

    Mar 25 09:59 ET

  • GIANT BIOGENE: DATE OF BOARD MEETING

    Mar 11 06:36 ET

  • GIANT BIOGENE: INTERIM REPORT 2023

    Sep 27, 2023 05:09 ET

  • GIANT BIOGENE: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

    Aug 28, 2023 06:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      90.91%

    • Buy

      9.09%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg